Gastroenterology and Hepatology Continuing Medical Education

17-25 of 25

MinuteCE®
Improving Preventive Care of Patients With Hepatic Encephalopathy: Navigating the Subtleties and Beyond
Robert S. Brown, Jr., MD, MPH; Steven Flamm, MD
1.00 credit 9 episodes
- Robert S. Brown, Jr., MD, MPH
- Steven Flamm, MD
1.00 credit 9 episodes
Hepatic Encephalopathy: Tipping the Balance 
Hepatic Encephalopathy: Tipping the Balance 
MinuteCE®
Hepatic Encephalopathy: Tipping the Balance 
Robert Brown Jr, MD, MPH; Steven Flamm, MD
1.00 program credit
- Robert Brown Jr, MD, MPH
- Steven Flamm, MD
1.00 program credit
Hepatic Encephalopathy: What's Sarcopenia Got to Do With It?
Hepatic Encephalopathy: What's Sarcopenia Got to Do With It?
MinuteCE®
Hepatic Encephalopathy: What's Sarcopenia Got to Do With It?
Robert Brown Jr, MD, MPH; Steven Flamm, MD
1.00 program credit
- Robert Brown Jr, MD, MPH
- Steven Flamm, MD
1.00 program credit
The Clinical Spectrum of Hepatic Encephalopathy 
The Clinical Spectrum of Hepatic Encephalopathy 
MinuteCE®
The Clinical Spectrum of Hepatic Encephalopathy 
Robert Brown Jr, MD, MPH; Steven Flamm, MD
1.00 program credit
- Robert Brown Jr, MD, MPH
- Steven Flamm, MD
1.00 program credit
Pivotal Data in Anti-PD-1 Strategies for HER2-Negative Upper GI Cancers  
Pivotal Data in Anti-PD-1 Strategies for HER2-Negative Upper GI Cancers  
MinuteCE®
Pivotal Data in Anti-PD-1 Strategies for HER2-Negative Upper GI Cancers  
James M. Cleary, MD, PhD
0.50 program credits
- James M. Cleary, MD, PhD
0.50 program credits
MinuteCE®
Partnering with Patients: Improving First-Line Treatment Selection in Upper GI Cancers Through Shared Decision-Making  
James M. Cleary, MD, PhD
0.50 credits 4 episodes
- James M. Cleary, MD, PhD
0.50 credits 4 episodes
Distinguishing First-Line Treatment Adverse Event Profiles in HER2-Negative Upper GI Cancers
Distinguishing First-Line Treatment Adverse Event Profiles in HER2-Negative Upper GI Cancers
MinuteCE®
Distinguishing First-Line Treatment Adverse Event Profiles in HER2-Negative Upper GI Cancers
James M. Cleary, MD, PhD
0.50 program credits
- James M. Cleary, MD, PhD
0.50 program credits
Guideline Recommendations in First-Line Treatment of HER2-Negative Upper GI Cancers
Guideline Recommendations in First-Line Treatment of HER2-Negative Upper GI Cancers
MinuteCE®
Guideline Recommendations in First-Line Treatment of HER2-Negative Upper GI Cancers
James M. Cleary, MD, PhD
0.50 program credits
- James M. Cleary, MD, PhD
0.50 program credits
Quick Case: Strategizing Treatment Selection in HER2-/PD-L1+ Gastric Cancer
Quick Case: Strategizing Treatment Selection in HER2-/PD-L1+ Gastric Cancer
MinuteCE®
Quick Case: Strategizing Treatment Selection in HER2-/PD-L1+ Gastric Cancer
James M. Cleary, MD, PhD
0.50 program credits
- James M. Cleary, MD, PhD
0.50 program credits

Previous
1
2
Next

2/2